Nov 3, 8:05 AM ET
DuPont de Nemours, Inc. reported third-quarter 2026 net sales of $1.9 billion and GAAP EPS from continuing operations of $1.24, exceeding its prior guidance. Driven by organic growth and strong operating leverage, management raised its full-year 2026 financial guidance.
- Net sales of $1.9 billion increased 4% year-over-year, with organic sales up 5%.
- GAAP EPS from continuing operations was $1.24, and adjusted EPS was $2.09 for the third quarter of 2026.
- Full-year 2026 guidance was raised to approximately $7.19 billion in net sales and $7.47 to $7.52 in adjusted EPS.
- The company completed a $250 million accelerated share purchase in the third quarter of 2026.
Read the filing on SEC.gov ↗
Sep 10, 7:06 AM ET
On September 9, 2026, DuPont, Chemours and Corteva entered a settlement with the State of North Carolina and 11 local entities to resolve PFAS-related claims, including claims tied to the Fayetteville Works facility and AFFF-related contamination. The settlement is subject to entry of orders dismissing the covered claims, and DuPont recorded a probable loss of about $125 million in the second quarter of 2026, which the press release says is materially covered by existing accruals.
- Aggregate cash payment of $455 million to the plaintiffs, payable over 15 years, shared under the 2021 MOU; $18 million is attributed to PFAS contamination unrelated to Fayetteville Works.
- DuPont recorded a probable loss of about $125 million in Q2 2026 within discontinued operations, before Qnity Electronics' reimbursement of 44% of DuPont's share.
- DuPont and Corteva will establish a $135 million Reserve Fund, accessible only if Chemours fails to perform under its 2019 Consent Order with the State.
- Future MOU escrow contributions, including the one due in September 2026, will be considered satisfied by the New Jersey and North Carolina settlement payments.
Read the filing on SEC.gov ↗
Aug 4, 6:08 AM ET
DuPont reported second quarter 2026 results with net sales of $1.8 billion, up 4%, and adjusted EPS of $1.88, up 48% from $1.27 a year earlier. The company raised its full-year 2026 guidance and said it intends to repurchase $250 million of shares in the third quarter, which points to higher earnings and cash returns for shareholders.
- Net sales of $1,819 million rose 4% from $1,749 million; organic sales also rose 4%
- GAAP EPS from continuing operations was $1.37, versus $0.17 a year earlier
- Full-year 2026 adjusted EPS guidance midpoint raised to $7.24 per share; operating EBITDA midpoint raised to approximately $1.76 billion
- Intent to repurchase $250 million of shares in the third quarter
Read the filing on SEC.gov ↗
May 5, 6:08 AM ET
DuPont reported first quarter 2026 net sales of $1.7 billion, up 4%, and GAAP earnings per share from continuing operations of $0.36, up from $0.19 a year earlier. The company also raised its full-year 2026 guidance and announced a $275 million accelerated share repurchase, which would return capital to shareholders.
- Q1 2026 net sales of $1,681 million, up 4% from $1,612 million; organic sales up 2%
- Adjusted EPS of $0.55 versus $0.36 a year earlier; GAAP EPS from continuing operations of $0.36 versus $0.19
- Full-year 2026 adjusted EPS guidance of $2.35 to $2.40; full-year net sales guidance of $7,155 million to $7,215 million
- Completed the Aramids business divestiture on April 1, 2026 and announced a $275 million accelerated share repurchase
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.